PROSPECTS AND OPPORTUNITIES
Demographic shifts and active lifestyles are set to drive steady growth in analgesics
Across the forecast period, analgesics in Norway is expected to record continued positive growth in retail value terms. However, this growth will increasingly be shaped by demographic and lifestyle trends, with volume sales largely driven by an ageing population and the widespread use of screens contributing to headaches, neck pain, and wrist discomfort.
Minimal digital disruption is expected, however, retail e-commerce will continue to grow
Innovation is expected to remain limited in systemic analgesics during the forecast period due to the dominance of Paracet and Ibux from Karo Pharma. These two brands, which account for the majority of sales, are recommended by health professionals, and are trusted by most Norwegian consumers.
Health and wellness trends are set to sustain modest but steady demand
Norway’s strong health and wellness culture will continue to shape demand for analgesics over the forecast period. The trend is especially visible in topical formats, which have benefited from Norwegians’ highly active lifestyles.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Norway with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Norway, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Norway report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Norway?
- Which are the leading brands in Analgesics in Norway?
- How are products distributed in Analgesics in Norway?
- How has the regulatory and operating environment for Analgesics changed in Norway?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in Norway - Category analysis
KEY DATA FINDINGS
Paracetamol and ibuprofen remain core to sales of analgesics in Norway
Karo Pharma maintains its lead while Haleon Norway gains ground in 2025
Pharmacies lead distribution while retail e-commerce gains momentum
Demographic shifts and active lifestyles are set to drive steady growth in analgesics
Minimal digital disruption is expected, however, retail e-commerce will continue to grow
Health and wellness trends are set to sustain modest but steady demand
Consumer Health in Norway - Industry Overview
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for Consumer Health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!